Chemotherapy-Induced Neutropenia (CIN) Market is driven by Growth Factor Therapies
The Chemotherapy Induced Neutropenia (CIN) Market encompasses treatments designed to prevent and manage the severe drop in neutrophil counts that often accompanies cytotoxic cancer therapies. Key products include granulocyte colony-stimulating factors (G-CSFs) such as filgrastim and pegfilgrastim, biosimilars offering cost advantages, and emerging small molecules that boost immune recovery....
0 Comments 0 Shares 198 Views 0 Reviews